Parallel Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
742
-233
| -24% | -$122K | 0.01% | 726 |
|
|
2025
Q1 | $618K | Sell |
975
-129
| -12% | -$81.8K | 0.01% | 510 |
|
|
2024
Q4 | $786K | Sell |
1,104
-220
| -17% | -$157K | 0.02% | 455 |
|
|
2024
Q3 | $1.39M | Buy |
1,324
+73
| +6% | +$76.8K | 0.03% | 305 |
|
|
2024
Q2 | $1.32M | Buy |
1,251
+100
| +9% | +$105K | 0.03% | 299 |
|
|
2024
Q1 | $1.11M | Buy |
1,151
+166
| +17% | +$160K | 0.03% | 338 |
|
|
2023
Q4 | $865K | Sell |
985
-628
| -39% | -$551K | 0.03% | 366 |
|
|
2023
Q3 | $1.33M | Buy |
1,613
+72
| +5% | +$59.3K | 0.04% | 259 |
|
|
2023
Q2 | $1.11M | Sell |
1,541
-9
| -0.6% | -$6.47K | 0.04% | 302 |
|
|
2023
Q1 | $1.27M | Sell |
1,550
-60
| -4% | -$49.3K | 0.04% | 272 |
|
|
2022
Q4 | $1.16M | Sell |
1,610
-103
| -6% | -$74.3K | 0.05% | 233 |
|
|
2022
Q3 | $1.18M | Sell |
1,713
-132
| -7% | -$90.9K | 0.05% | 213 |
|
|
2022
Q2 | $1.09M | Buy |
1,845
+790
| +75% | +$467K | 0.05% | 226 |
|
|
2022
Q1 | $730K | Sell |
1,055
-50
| -5% | -$34.6K | 0.03% | 331 |
|
|
2021
Q4 | $698K | Buy |
1,105
+63
| +6% | +$39.8K | 0.03% | 346 |
|
|
2021
Q3 | $631K | Buy |
1,042
+441
| +73% | +$267K | 0.03% | 347 |
|
|
2021
Q2 | $336K | Buy |
601
+97
| +19% | +$54.2K | 0.01% | 497 |
|
|
2021
Q1 | $238K | Sell |
504
-193
| -28% | -$91.1K | 0.01% | 576 |
|
|
2020
Q4 | $337K | Sell |
697
-194
| -22% | -$93.8K | 0.02% | 419 |
|
|
2020
Q3 | $499K | Buy |
891
+236
| +36% | +$132K | 0.03% | 307 |
|
|
2020
Q2 | $408K | Buy |
655
+101
| +18% | +$62.9K | 0.03% | 344 |
|
|
2020
Q1 | $270K | Buy |
554
+203
| +58% | +$98.9K | 0.02% | 371 |
|
|
2019
Q4 | $132K | Buy |
351
+73
| +26% | +$27.5K | 0.01% | 660 |
|
|
2019
Q3 | $77K | Sell |
278
-52
| -16% | -$14.4K | 0.01% | 807 |
|
|
2019
Q2 | $103K | Sell |
330
-65
| -16% | -$20.3K | 0.01% | 648 |
|
|
2019
Q1 | $162K | Buy |
395
+25
| +7% | +$10.3K | 0.02% | 469 |
|
|
2018
Q4 | $138K | Sell |
370
-99
| -21% | -$36.9K | 0.02% | 453 |
|
|
2018
Q3 | $189K | Buy |
469
+63
| +16% | +$25.4K | 0.02% | 400 |
|
|
2018
Q2 | $140K | Sell |
406
-57
| -12% | -$19.7K | 0.02% | 450 |
|
|
2018
Q1 | $159K | Sell |
463
-38
| -8% | -$13.1K | 0.02% | 385 |
|
|
2017
Q4 | $188K | Sell |
501
-125
| -20% | -$46.9K | 0.03% | 330 |
|
|
2017
Q3 | $246K | Sell |
626
-25
| -4% | -$9.82K | 0.04% | 281 |
|
|
2017
Q2 | $320K | Sell |
651
-435
| -40% | -$214K | 0.06% | 236 |
|
|
2017
Q1 | $442K | Buy |
1,086
+59
| +6% | +$24K | 0.09% | 166 |
|
|
2016
Q4 | $377K | Buy |
+1,027
| New | +$377K | 0.09% | 164 |
|